| DM-HP (n = 73) | DM + HP (n = 103) | P value |
---|---|---|---|
Demographics | Â | Â | Â |
sex, male, n(%) | 39(53) | 60(58) | 0.623 |
Age, years | 57±11 | 61±11 | 0.075 |
BSA, m2 | 1.65±0.15 | 1.70±0.20 | 0.008 |
Dyslipidemia, n(%) | 27(37.0) | 42(40.8) | 0.716 |
Current smoking, n(%) | 13(17.8) | 35(33.9) | 0.022 |
SBP, mmHg | 125±14 | 134±17 | < 0.001 |
DBP, mmHg | 78±12 | 80±12 | 0.356 |
Laboratory indices | Â | Â | Â |
HbA1c (%) | 7.34±1.70 | 7.00±1.22 | 0.179 |
TG, mmol/l | 2.00±1.77 | 1.62±1.09 | 0.075 |
TC, mmol/l | 4.49±1.40 | 4.05±1.20 | 0.027 |
HDL-C, mmol/l | 1.21 + 0.34 | 1.23±0.38 | 0.718 |
LDL-C, mmol/l | 2.60±1.47 | 2.31±1.02 | 0.118 |
Medications, n (%) | Â | Â | Â |
ACEI/ARB | 12(16.4) | 87(84.5) | < 0.001 |
Beta-blocker | 4(5.5) | 13(12.6) | < 0.001 |
Calcium channel blocker | 3(4.1) | 27(26.2) | < 0.001 |
Diuretics | 5(6.8) | 25(24.3) | 0.005 |
anti-diabetic treatment, n (%) | Â | Â | Â |
insulin | 11(15.1) | 18(17.5) | 0.671 |
metformin | 12(16.4) | 21(20.4) | 0.508 |
sulfonylurea | 18(24.7) | 27(26.3) | 0.816 |
α-glucosidase inhibitor | 20(27.4) | 24(23.3) | 0.536 |
other | 2(2.7) | 4(3.9) | 0.479 |
non-drug | 13(17.8) | 16(15.6) | 0.689 |